Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment

Novel coronavirus first appeared in Wuhan, China, in December 2019, and it speedily expanded globally. Some medications which are used to treat other diseases seem to be effective in treating COVID-19 even without explicit support. The existing drugs that are summarized in this review primarily focu...

Full description

Bibliographic Details
Main Authors:	Zemene Demelash Kifle, Akeberegn Gorems Ayele, Engidaw Fentahun Enyew
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Environmental and Public Health
Online Access:	http://dx.doi.org/10.1155/2021/6631721

Similar Items

Roles of existing drug and drug targets for COVID-19 management
by: Akeberegn Gorems Ayele, et al.
Published: (2021-09-01)

Evaluation of In Vivo Antidiabetic, In Vitro α-Amylase Inhibitory, and In Vitro Antioxidant Activity of Leaves Crude Extract and Solvent Fractions of Fresen (Melianthaceae)
by: Zemene Demelash Kifle, et al.
Published: (2020-07-01)

A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment
by: Zemene Demelash Kifle MSc, et al.
Published: (2021-03-01)

Drug Repurposing in the Treatment of COVID-19
by: Mehmet SOYLU, et al.
Published: (2020-12-01)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
by: Ulf Norinder, et al.
Published: (2020-10-01)

Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
by: Zemene Demelash Kifle
Published: (2021-09-01)

Artificial intelligence in COVID-19 drug repurposing
by: Yadi Zhou, PhD, et al.
Published: (2020-12-01)

Editorial: Drug Repurposing for COVID-19 Therapy
by: Rafael Maldonado, et al.
Published: (2021-08-01)

Artificial intelligence approach fighting COVID-19 with repurposing drugs
by: Yi-Yu Ke, et al.
Published: (2020-08-01)

Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
by: Levin Thomas, et al.
Published: (2021-08-01)

Impact of repurposed drugs on the symptomatic COVID-19 patients
by: Iqbal Hussain, et al.
Published: (2021-01-01)

Repurposing existing drugs for COVID-19: an endocrinology perspective
by: Flavio A. Cadegiani
Published: (2020-09-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

A Rapid Strategy for Repurposing Drugs for COVID-19
by: Maryam Khoubnasabjafari, et al.
Published: (2020-11-01)

Computational-based drug repurposing methods in COVID-19
by: Yosef Masoudi-Sobhanzadeh
Published: (2020-07-01)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
by: Miguel Angel Martinez
Published: (2021-03-01)

Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
by: Giorgio Frega, et al.
Published: (2020-10-01)

A Brief Overview of Current Drug Repurposing Approaches for COVID-19 Management
by: Pedro da Fonseca Soares Rodrigues, et al.
Published: (2020-04-01)

Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Drug repurposing against COVID-19: focus on anticancer agents
by: Gennaro Ciliberto, et al.
Published: (2020-05-01)

Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
by: Dina B. Mahmoud, et al.
Published: (2020-07-01)

Drug Repurposing and Dosage Form Development of Anti-COVID-19
by: Kevin Kwok
Published: (2021-04-01)

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
by: Christian A. Devaux, et al.
Published: (2021-09-01)

Combating COVID-19: The role of drug repurposing and medicinal plants
by: Shah A. Khan, et al.
Published: (2021-04-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs
by: Veronique Michaud, et al.
Published: (2021-01-01)

DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing
by: Mohamed Abdel-Basset, et al.
Published: (2020-01-01)

Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
by: Mahmudul Hasan, et al.
Published: (2021-08-01)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
by: Fatih M. Uckun, et al.
Published: (2021-03-01)

477 Deep learning to drive COVID-19 rapid drug repurposing
by: Jenny Zhang, et al.
Published: (2020-11-01)

In silico drug repurposing in COVID-19: A network-based analysis
by: Pasquale Sibilio, et al.
Published: (2021-10-01)

Buying time: Drug repurposing to treat the host in COVID‐19H
by: Jennifer H. Martin, et al.
Published: (2020-08-01)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01)

Chloroquine: An Old to be Repurposed Drug For COVID-19 Infection (Risk and Benefit)
by: Oki Nugraha Putra, et al.
Published: (2020-07-01)

Network bioinformatics analysis provides insight into drug repurposing for COVID-19
by: Xu Li, et al.
Published: (2021-06-01)

Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19
by: Michael A. Kiebish, et al.
Published: (2021-03-01)

Drug Repurposing Advances, Scopes and Opportunities in Drug Discovery
Published: (2023)

Repurposing of Drugs Targeting YAP-TEAD Functions
by: Gian Marco Elisi, et al.
Published: (2018-09-01)